{"transactions":[{"id":4005,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:58.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":4313,"source":{"system":"sec-edgar","filing":"0001193125-26-382475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1879013/000119312526382475/ownership.xml","form_type":"4"}},{"id":4004,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:58.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":164,"price":113.38,"value":18594.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":4149,"source":{"system":"sec-edgar","filing":"0001193125-26-382475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1879013/000119312526382475/ownership.xml","form_type":"4"}},{"id":689780,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-12T20:26:08.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":110000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001193125-26-346942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346942/ownership.xml","form_type":"4"}},{"id":689779,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-12T20:26:08.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":4770,"price":114.0371,"value":543956.967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $113.98 to $114.24 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":3985,"source":{"system":"sec-edgar","filing":"0001193125-26-346942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346942/ownership.xml","form_type":"4"}},{"id":689778,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-12T20:26:08.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":11530,"price":113.1772,"value":1304933.116,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.80 to $113.75 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8755,"source":{"system":"sec-edgar","filing":"0001193125-26-346942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346942/ownership.xml","form_type":"4"}},{"id":689777,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-12T20:26:08.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":16300,"price":21.65,"value":352895.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":20285,"source":{"system":"sec-edgar","filing":"0001193125-26-346942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346942/ownership.xml","form_type":"4"}},{"id":694597,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-06T22:44:47.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":false,"shares":3700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":126300,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":3700},"source":{"system":"sec-edgar","filing":"0001193125-26-338637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526338637/ownership.xml","form_type":"4"}},{"id":694596,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-06T22:44:47.000Z","date":"2026-08-04","kind":"sale","planned":true,"acquired":false,"shares":3700,"price":113.1248,"value":418561.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.92 to $113.455 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":3985,"source":{"system":"sec-edgar","filing":"0001193125-26-338637","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526338637/ownership.xml","form_type":"4"}},{"id":694595,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-06T22:44:47.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":true,"shares":3700,"price":21.65,"value":80105.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7685,"source":{"system":"sec-edgar","filing":"0001193125-26-338637","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526338637/ownership.xml","form_type":"4"}},{"id":713078,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-08T23:54:54.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":130000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-298865","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526298865/ownership.xml","form_type":"4"}},{"id":713077,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-07-08T23:54:54.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":952,"price":93.5383,"value":89048.4616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $93.52 to $93.665 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":3985,"source":{"system":"sec-edgar","filing":"0001193125-26-298865","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526298865/ownership.xml","form_type":"4"}},{"id":713076,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-07-08T23:54:54.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":19048,"price":93.1059,"value":1773481.1832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $92.50 to $93.43 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":4937,"source":{"system":"sec-edgar","filing":"0001193125-26-298865","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526298865/ownership.xml","form_type":"4"}},{"id":713075,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-07-08T23:54:54.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23985,"source":{"system":"sec-edgar","filing":"0001193125-26-298865","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526298865/ownership.xml","form_type":"4"}},{"id":750114,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T20:49:31.000Z","date":"2026-06-02","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":150000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-257618","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526257618/ownership.xml","form_type":"4"}},{"id":750113,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-06-04T20:49:31.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":70.6,"value":1412000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $70.44 to $70.86 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":3985,"source":{"system":"sec-edgar","filing":"0001193125-26-257618","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526257618/ownership.xml","form_type":"4"}},{"id":750112,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-06-04T20:49:31.000Z","date":"2026-06-02","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23985,"source":{"system":"sec-edgar","filing":"0001193125-26-257618","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526257618/ownership.xml","form_type":"4"}},{"id":752884,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:24:38.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":3985,"source":{"system":"sec-edgar","filing":"0001193125-26-256015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256015/ownership.xml","form_type":"4"}},{"id":752883,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-06-03T23:24:38.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":877,"price":70.44,"value":61775.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on June 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":3108,"source":{"system":"sec-edgar","filing":"0001193125-26-256015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526256015/ownership.xml","form_type":"4"}},{"id":788954,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-05-07T20:30:14.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":170000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-212118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526212118/ownership.xml","form_type":"4"}},{"id":788953,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-07T20:30:14.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":51.83,"value":1036600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $51.60 to $52.05 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":2231,"source":{"system":"sec-edgar","filing":"0001193125-26-212118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526212118/ownership.xml","form_type":"4"}},{"id":788952,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-07T20:30:14.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":22231,"source":{"system":"sec-edgar","filing":"0001193125-26-212118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526212118/ownership.xml","form_type":"4"}},{"id":812878,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-08T23:34:57.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":190000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-148497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526148497/ownership.xml","form_type":"4"}},{"id":812877,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-08T23:34:57.000Z","date":"2026-04-07","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":40.97,"value":819400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $40.85 to $41.30 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":2231,"source":{"system":"sec-edgar","filing":"0001193125-26-148497","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526148497/ownership.xml","form_type":"4"}},{"id":812876,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-08T23:34:57.000Z","date":"2026-04-07","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":22231,"source":{"system":"sec-edgar","filing":"0001193125-26-148497","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526148497/ownership.xml","form_type":"4"}},{"id":829894,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-24T20:54:46.000Z","date":"2026-03-20","kind":"exercise","planned":true,"acquired":false,"shares":11767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":210000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":11767},"source":{"system":"sec-edgar","filing":"0001193125-26-122136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526122136/ownership.xml","form_type":"4"}},{"id":829893,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-24T20:54:46.000Z","date":"2026-03-20","kind":"sale","planned":true,"acquired":false,"shares":11767,"price":36.01,"value":423729.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $35.97 to $36.24 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":2231,"source":{"system":"sec-edgar","filing":"0001193125-26-122136","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526122136/ownership.xml","form_type":"4"}},{"id":829892,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-24T20:54:46.000Z","date":"2026-03-20","kind":"exercise","planned":true,"acquired":true,"shares":11767,"price":21.65,"value":254755.55,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13998,"source":{"system":"sec-edgar","filing":"0001193125-26-122136","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526122136/ownership.xml","form_type":"4"}},{"id":856841,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-06T21:30:18.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":8233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":221767,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":8233},"source":{"system":"sec-edgar","filing":"0001193125-26-096653","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526096653/ownership.xml","form_type":"4"}},{"id":856840,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-06T21:30:18.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":8233,"price":35.9949,"value":296346.0117,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $35.97 to $36.05 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":2231,"source":{"system":"sec-edgar","filing":"0001193125-26-096653","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526096653/ownership.xml","form_type":"4"}},{"id":856839,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-06T21:30:18.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":true,"shares":8233,"price":21.65,"value":178244.45,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10464,"source":{"system":"sec-edgar","filing":"0001193125-26-096653","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526096653/ownership.xml","form_type":"4"}},{"id":863055,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-05T01:21:33.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":2231,"source":{"system":"sec-edgar","filing":"0001193125-26-092157","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092157/ownership.xml","form_type":"4"}},{"id":863054,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-05T01:21:33.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":498,"price":35.97,"value":17913.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":1733,"source":{"system":"sec-edgar","filing":"0001193125-26-092157","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526092157/ownership.xml","form_type":"4"}},{"id":870152,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T23:13:48.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercise ratably in equal installments on each monthly anniversary of February 27, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":35.7,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001193125-26-089009","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526089009/ownership.xml","form_type":"4"}},{"id":918170,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-02-05T22:42:50.000Z","date":"2026-02-03","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":230000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-039717","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526039717/ownership.xml","form_type":"4"}},{"id":918169,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-05T22:42:50.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":40.8667,"value":817334.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $40.71 to $41.2804 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1235,"source":{"system":"sec-edgar","filing":"0001193125-26-039717","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526039717/ownership.xml","form_type":"4"}},{"id":918168,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-05T22:42:50.000Z","date":"2026-02-03","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"balance_after":21235,"source":{"system":"sec-edgar","filing":"0001193125-26-039717","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526039717/ownership.xml","form_type":"4"}},{"id":943586,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-01-09T01:35:51.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":250000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-008023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526008023/ownership.xml","form_type":"4"}},{"id":943585,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-09T01:35:51.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":35.1828,"value":703656.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $34.96 to $35.50 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1235,"source":{"system":"sec-edgar","filing":"0001193125-26-008023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526008023/ownership.xml","form_type":"4"}},{"id":943584,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-09T01:35:51.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"balance_after":21235,"source":{"system":"sec-edgar","filing":"0001193125-26-008023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526008023/ownership.xml","form_type":"4"}},{"id":982414,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-12-04T02:19:27.000Z","date":"2025-12-02","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully exercisable."}],"balance_after":270000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-307282","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307282/ownership.xml","form_type":"4"}},{"id":982413,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-04T02:19:27.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":640,"price":80.875,"value":51760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."}],"balance_after":1235,"source":{"system":"sec-edgar","filing":"0001193125-25-307282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307282/ownership.xml","form_type":"4"}},{"id":982412,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-04T02:19:27.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":19360,"price":80.0499,"value":1549766.064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.78 to $80.68 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001193125-25-307282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307282/ownership.xml","form_type":"4"}},{"id":982411,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-04T02:19:27.000Z","date":"2025-12-02","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"balance_after":21235,"source":{"system":"sec-edgar","filing":"0001193125-25-307282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307282/ownership.xml","form_type":"4"}},{"id":982410,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-04T02:19:27.000Z","date":"2025-12-02","kind":"other","planned":true,"acquired":true,"shares":787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transfer of shares without consideration to the Reporting Person."}],"balance_after":1235,"source":{"system":"sec-edgar","filing":"0001193125-25-307282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307282/ownership.xml","form_type":"4"}},{"id":982409,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-04T02:19:27.000Z","date":"2025-12-02","kind":"gift","planned":true,"acquired":false,"shares":787,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"The Lake Bainwood Living Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents the shares held by The Lake Bainwood Living Trust of which the Reporting Person is a co-trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-307282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307282/ownership.xml","form_type":"4"}},{"id":982408,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-04T02:19:27.000Z","date":"2025-12-01","kind":"grant","planned":true,"acquired":true,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."}],"balance_after":448,"source":{"system":"sec-edgar","filing":"0001193125-25-307282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307282/ownership.xml","form_type":"4"}},{"id":982407,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-04T02:19:27.000Z","date":"2025-12-01","kind":"grant","planned":true,"acquired":true,"shares":224,"price":79.78,"value":17870.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."}],"balance_after":224,"source":{"system":"sec-edgar","filing":"0001193125-25-307282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307282/ownership.xml","form_type":"4"}},{"id":982385,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:08:48.000Z","date":"2025-11-25","kind":"sale","planned":false,"acquired":false,"shares":4500,"price":80.9045,"value":364070.25,"ownership":{"direct":false,"nature":"The Lake Bainwood Living Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.81 to $81.085 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"On November 26, 2025, the Reporting Person filed a Form 4 that inadvertently reported that the 4,500 shares sold were held directly. By this amendment, the Reporting Person corrects such report by reporting that the shares sold were held indirectly by The Lake Bainwood Living Trust of which the Reporting Person is a co-trustee as a result of the transfer that occurred on November 17, 2025, now reported in this amendment."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents the shares held by The Lake Bainwood Living Trust of which the Reporting Person is a co-trustee."}],"balance_after":787,"source":{"system":"sec-edgar","filing":"0001193125-25-307194","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307194/ownership.xml","form_type":"4/A","original_submission_date":"2025-11-25"}},{"id":982384,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:08:48.000Z","date":"2025-11-17","kind":"other","planned":false,"acquired":true,"shares":5287,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"The Lake Bainwood Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was inadvertently omitted from previous filings."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Transfer of shares without consideration to The Lake Bainwood Living Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents the shares held by The Lake Bainwood Living Trust of which the Reporting Person is a co-trustee."}],"balance_after":5287,"source":{"system":"sec-edgar","filing":"0001193125-25-307194","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307194/ownership.xml","form_type":"4/A","original_submission_date":"2025-11-25"}},{"id":982383,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:08:48.000Z","date":"2025-11-17","kind":"gift","planned":false,"acquired":false,"shares":5287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was inadvertently omitted from previous filings."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-307194","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307194/ownership.xml","form_type":"4/A","original_submission_date":"2025-11-25"}},{"id":987699,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-26T22:22:58.000Z","date":"2025-11-25","kind":"sale","planned":false,"acquired":false,"shares":4500,"price":80.9045,"value":364070.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.81 to $81.085 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":787,"source":{"system":"sec-edgar","filing":"0001193125-25-300821","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525300821/ownership.xml","form_type":"4"}},{"id":1005186,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-11-07T22:10:03.000Z","date":"2025-11-05","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":290000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-272572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525272572/ownership.xml","form_type":"4"}},{"id":1005185,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-07T22:10:03.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":300,"price":76.28,"value":22884.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."}],"balance_after":5287,"source":{"system":"sec-edgar","filing":"0001193125-25-272572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525272572/ownership.xml","form_type":"4"}},{"id":1005184,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-07T22:10:03.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":13164,"price":75.6365,"value":995678.886,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $75.185 to $76.17 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":5587,"source":{"system":"sec-edgar","filing":"0001193125-25-272572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525272572/ownership.xml","form_type":"4"}},{"id":1005183,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-07T22:10:03.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":6536,"price":74.7489,"value":488558.8104,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $74.17 to $75.165 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":18751,"source":{"system":"sec-edgar","filing":"0001193125-25-272572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525272572/ownership.xml","form_type":"4"}},{"id":1005182,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-07T22:10:03.000Z","date":"2025-11-05","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"balance_after":25287,"source":{"system":"sec-edgar","filing":"0001193125-25-272572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525272572/ownership.xml","form_type":"4"}},{"id":1021034,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-10-09T21:51:46.000Z","date":"2025-10-07","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":310000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-236107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525236107/ownership.xml","form_type":"4"}},{"id":1021033,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-10-09T21:51:46.000Z","date":"2025-10-07","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":89.9391,"value":1798782.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $89.85 to $90.18 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":5287,"source":{"system":"sec-edgar","filing":"0001193125-25-236107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525236107/ownership.xml","form_type":"4"}},{"id":1021032,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-10-09T21:51:46.000Z","date":"2025-10-07","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"balance_after":25287,"source":{"system":"sec-edgar","filing":"0001193125-25-236107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525236107/ownership.xml","form_type":"4"}},{"id":1033954,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-09-23T21:06:36.000Z","date":"2025-09-19","kind":"gift","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a donation by the Reporting Person to Fidelity Charitable Giving Account."}],"balance_after":5287,"source":{"system":"sec-edgar","filing":"0001193125-25-213559","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525213559/ownership.xml","form_type":"4"}},{"id":1048539,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-09-04T23:59:36.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":330000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-196319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196319/ownership.xml","form_type":"4"}},{"id":1048538,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:59:36.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":4406,"price":70.8478,"value":312155.4068,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $70.725 to $71.08 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0001193125-25-196319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196319/ownership.xml","form_type":"4"}},{"id":1048537,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:59:36.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":15594,"price":70.392,"value":1097692.848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $69.725 to $70.72 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":9893,"source":{"system":"sec-edgar","filing":"0001193125-25-196319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196319/ownership.xml","form_type":"4"}},{"id":1048536,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:59:36.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"balance_after":25487,"source":{"system":"sec-edgar","filing":"0001193125-25-196319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196319/ownership.xml","form_type":"4"}},{"id":1069289,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-08-12T23:19:34.000Z","date":"2025-08-08","kind":"exercise","planned":true,"acquired":false,"shares":35007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":350000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":35007},"source":{"system":"sec-edgar","filing":"0001193125-25-179180","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525179180/ownership.xml","form_type":"4"}},{"id":1069288,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-08-12T23:19:34.000Z","date":"2025-08-08","kind":"sale","planned":true,"acquired":false,"shares":35007,"price":71.77,"value":2512452.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0001193125-25-179180","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525179180/ownership.xml","form_type":"4"}},{"id":1069287,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-08-12T23:19:34.000Z","date":"2025-08-08","kind":"exercise","planned":true,"acquired":true,"shares":35007,"price":21.65,"value":757901.55,"ownership":{"direct":true},"balance_after":40494,"source":{"system":"sec-edgar","filing":"0001193125-25-179180","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525179180/ownership.xml","form_type":"4"}},{"id":1072591,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-08-07T23:17:05.000Z","date":"2025-08-05","kind":"exercise","planned":true,"acquired":false,"shares":14,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":385007,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":14},"source":{"system":"sec-edgar","filing":"0000950170-25-105330","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025105330/ownership.xml","form_type":"4"}},{"id":1072590,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-08-07T23:17:05.000Z","date":"2025-08-05","kind":"sale","planned":true,"acquired":false,"shares":14,"price":71.77,"value":1004.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0000950170-25-105330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025105330/ownership.xml","form_type":"4"}},{"id":1072589,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-08-07T23:17:05.000Z","date":"2025-08-05","kind":"exercise","planned":true,"acquired":true,"shares":14,"price":21.65,"value":303.1,"ownership":{"direct":true},"balance_after":5501,"source":{"system":"sec-edgar","filing":"0000950170-25-105330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025105330/ownership.xml","form_type":"4"}},{"id":1084237,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-07-21T23:10:34.000Z","date":"2025-07-18","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":385021,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000950170-25-097370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097370/ownership.xml","form_type":"4"}},{"id":1084236,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-07-21T23:10:34.000Z","date":"2025-07-17","kind":"exercise","planned":true,"acquired":false,"shares":4379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":385521,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":4379},"source":{"system":"sec-edgar","filing":"0000950170-25-097370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097370/ownership.xml","form_type":"4"}},{"id":1084235,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-07-21T23:10:34.000Z","date":"2025-07-18","kind":"sale","planned":true,"acquired":false,"shares":500,"price":73.442,"value":36721.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.40 to $73.47 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0000950170-25-097370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097370/ownership.xml","form_type":"4"}},{"id":1084234,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-07-21T23:10:34.000Z","date":"2025-07-18","kind":"exercise","planned":true,"acquired":true,"shares":500,"price":21.65,"value":10825.0,"ownership":{"direct":true},"balance_after":5987,"source":{"system":"sec-edgar","filing":"0000950170-25-097370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097370/ownership.xml","form_type":"4"}},{"id":1084233,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-07-21T23:10:34.000Z","date":"2025-07-17","kind":"sale","planned":true,"acquired":false,"shares":4379,"price":73.4811,"value":321773.7369,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.40 to $73.74 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0000950170-25-097370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097370/ownership.xml","form_type":"4"}},{"id":1084232,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-07-21T23:10:34.000Z","date":"2025-07-17","kind":"exercise","planned":true,"acquired":true,"shares":4379,"price":21.65,"value":94805.35,"ownership":{"direct":true},"balance_after":9866,"source":{"system":"sec-edgar","filing":"0000950170-25-097370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097370/ownership.xml","form_type":"4"}},{"id":1093076,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-07-04T00:39:07.000Z","date":"2025-07-01","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":389900,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0000950170-25-094123","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025094123/ownership.xml","form_type":"4"}},{"id":1093075,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-07-04T00:39:07.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":73.505,"value":7350.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0000950170-25-094123","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025094123/ownership.xml","form_type":"4"}},{"id":1093074,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-07-04T00:39:07.000Z","date":"2025-07-01","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":21.65,"value":2165.0,"ownership":{"direct":true},"balance_after":5587,"source":{"system":"sec-edgar","filing":"0000950170-25-094123","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025094123/ownership.xml","form_type":"4"}},{"id":1114086,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-06-13T00:41:14.000Z","date":"2025-06-10","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":390000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-25-085755","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025085755/ownership.xml","form_type":"4"}},{"id":1114085,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-06-13T00:41:14.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":3082,"price":72.7494,"value":224213.6508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $72.70 to $72.97 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0000950170-25-085755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025085755/ownership.xml","form_type":"4"}},{"id":1114084,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-06-13T00:41:14.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":16918,"price":72.3644,"value":1224260.9192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $71.70 to $72.695 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":8569,"source":{"system":"sec-edgar","filing":"0000950170-25-085755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025085755/ownership.xml","form_type":"4"}},{"id":1114083,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-06-13T00:41:14.000Z","date":"2025-06-10","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":21.65,"value":433000.0,"ownership":{"direct":true},"balance_after":25487,"source":{"system":"sec-edgar","filing":"0000950170-25-085755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025085755/ownership.xml","form_type":"4"}},{"id":1140995,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-05-20T23:35:58.000Z","date":"2025-05-16","kind":"exercise","planned":true,"acquired":false,"shares":32262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":410000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":32262},"source":{"system":"sec-edgar","filing":"0000950170-25-075484","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025075484/ownership.xml","form_type":"4"}},{"id":1140994,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-05-20T23:35:58.000Z","date":"2025-05-16","kind":"sale","planned":true,"acquired":false,"shares":32262,"price":74.1744,"value":2393014.4928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.94 to $74.66 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0000950170-25-075484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025075484/ownership.xml","form_type":"4"}},{"id":1140993,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-05-20T23:35:58.000Z","date":"2025-05-16","kind":"exercise","planned":true,"acquired":true,"shares":32262,"price":21.65,"value":698472.3,"ownership":{"direct":true},"balance_after":37749,"source":{"system":"sec-edgar","filing":"0000950170-25-075484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025075484/ownership.xml","form_type":"4"}},{"id":1155363,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-05-09T00:20:53.000Z","date":"2025-05-06","kind":"exercise","planned":true,"acquired":false,"shares":7060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":442262,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":7060},"source":{"system":"sec-edgar","filing":"0000950170-25-067451","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025067451/ownership.xml","form_type":"4"}},{"id":1155362,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-05-09T00:20:53.000Z","date":"2025-05-06","kind":"sale","planned":true,"acquired":false,"shares":7060,"price":74.3134,"value":524652.604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0000950170-25-067451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025067451/ownership.xml","form_type":"4"}},{"id":1155361,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-05-09T00:20:53.000Z","date":"2025-05-06","kind":"exercise","planned":true,"acquired":true,"shares":7060,"price":21.65,"value":152849.0,"ownership":{"direct":true},"balance_after":12547,"source":{"system":"sec-edgar","filing":"0000950170-25-067451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025067451/ownership.xml","form_type":"4"}},{"id":1184519,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-04-03T00:08:27.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":false,"shares":678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":449322,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":678},"source":{"system":"sec-edgar","filing":"0000950170-25-049800","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025049800/ownership.xml","form_type":"4"}},{"id":1184518,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-04-03T00:08:27.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":678,"price":114.5118,"value":77639.0004,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.29 to $114.71 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0000950170-25-049800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025049800/ownership.xml","form_type":"4"}},{"id":1184517,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-04-03T00:08:27.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":true,"shares":678,"price":21.65,"value":14678.7,"ownership":{"direct":true},"balance_after":6165,"source":{"system":"sec-edgar","filing":"0000950170-25-049800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025049800/ownership.xml","form_type":"4"}},{"id":1231345,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T00:53:01.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":30000,"derivative":{"exercise_price":19.26,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-25-032747","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032747/ownership.xml","form_type":"4"}},{"id":1231344,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T00:53:01.000Z","date":"2025-02-28","kind":"grant","planned":true,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercise ratably in equal installments on each monthly anniversary of February 28, 2025 over a four-year period subject to the Reporting Person's continued service through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":60.58,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000950170-25-032747","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032747/ownership.xml","form_type":"4"}},{"id":1231343,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:53:01.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":59.07,"value":1181400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0000950170-25-032747","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032747/ownership.xml","form_type":"4"}},{"id":1231342,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:53:01.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":19.26,"value":385200.0,"ownership":{"direct":true},"balance_after":25487,"source":{"system":"sec-edgar","filing":"0000950170-25-032747","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032747/ownership.xml","form_type":"4"}},{"id":1343613,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-12-05T01:02:18.000Z","date":"2024-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":309,"price":57.68,"value":17823.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The closing price on November 29, 2024 was used to calculate the withholding obligation."}],"balance_after":5487,"source":{"system":"sec-edgar","filing":"0000950170-24-133448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024133448/ownership.xml","form_type":"4"}},{"id":1376099,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-11-06T00:48:50.000Z","date":"2024-11-04","kind":"exercise","planned":true,"acquired":false,"shares":3394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option vested and became exercisable with respect to 25% of the shares on the first anniversary of August 16, 2021 (the \"Vesting Commencement Date\") with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service."}],"balance_after":450000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":3394},"source":{"system":"sec-edgar","filing":"0000950170-24-121742","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024121742/ownership.xml","form_type":"4"}},{"id":1376098,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-11-06T00:48:50.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":false,"shares":6606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option vested and became exercisable with respect to 25% of the shares on the first anniversary of August 16, 2021 (the \"Vesting Commencement Date\") with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service."}],"balance_after":453394,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":6606},"source":{"system":"sec-edgar","filing":"0000950170-24-121742","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024121742/ownership.xml","form_type":"4"}},{"id":1376097,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-11-06T00:48:50.000Z","date":"2024-11-04","kind":"sale","planned":true,"acquired":false,"shares":3394,"price":48.97,"value":166204.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 609 shares underlying unvested restricted stock units granted to the Reporting Person by the Issuer on December 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":5796,"source":{"system":"sec-edgar","filing":"0000950170-24-121742","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024121742/ownership.xml","form_type":"4"}}],"next_cursor":"2024-11-06T00:48:50.000000Z,1376097"}